CAS RN: 1110813-31-4

Dacomitinib

Product Availability

Choose a grade to view its available package options.

11 package records11 with current stock4 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250110 100mg / 250mg / 1g / 5g Confirm by inquiry Shanghai 8-10 business days Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20251024 10mg In stock Inquiry
Batchno.20250221 250mg In stock Inquiry
Batchno.20250215 50mg In stock Inquiry
Batchno.20260219 5mg In stock Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250720 1ml In stock Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20251016 100mg In stock Shanghai, Tianjin Inquiry
Batchno.20250529 10g In stock Shanghai Inquiry
Batchno.20251110 1g In stock Shanghai Inquiry
Batchno.20260330 250mg In stock Shanghai, Shenzhen Inquiry
Batchno.20250714 5g In stock Shanghai Inquiry
  • Product code: ICTD5450
  • Purity/Analytical Methods: >98.0%(HPLC)
GET A QUOTE

1110813-31-4 / (E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide

Dacomitinib | PF-00299804 | Dacomitinib anhydrous

Standard CAS: 1110813-31-4 Multi CAS: Yes

Basic Information

CAS
1110813-31-4
Multi CAS
Yes
Molecular Formula
C24H25ClFN5O2
Molecular Weight
469.900000
Exact Mass
469.168081
SMILES
COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4
InChI
InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
InChIKey
LVXJQMNHJWSHET-AATRIKPKSA-N
Synonyms
Dacomitinib PF-00299804 Dacomitinib anhydrous Vizimpro dacomitinibum

Physical Properties

Melting Point
184-187 ºC

Computed Properties

Structural Parameters

Heavy atom count
33
Aromatic heavy atom count
16
Fraction Csp3
0.29
Rotatable bonds
7
H-bond acceptors
6
H-bond donors
2
Molar refractivity
128.84
TPSA
79.38

LogP / Solubility

WLOGP
5.16
MLOGP
4.57
XLogP3
4.4
Consensus LogP
4.71
Log S (ESOL)
-5.9
Class (ESOL)
Slightly soluble
Log S (Ali)
-7.14
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.83
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.93

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3

Get In Touch

Contact Us